Impact of COVID-19 on Patients With Psoriasis or Psoriatic Arthritis.

Authors

Philip Mease, P.J. Mease, MD, Swedish Medical Center/Providence St. Joseph Health, and University of Washington School of Medicine, Seattle, Washington, USAFollow
Peter Nash
Suzanne Grieb
Vinod Chandran

Document Type

Article

Publication Date

8-1-2023

Publication Title

The Journal of rheumatology

Keywords

washington; swedish; covid-19

Abstract

Given the impact of the coronavirus disease 2019 (COVID-19) on patients with psoriatic disease (PsD), a session was devoted at the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2022 annual meeting to discussing the current understanding of the risk of severe COVID-19 in patients with PsD. The effects of PsD and its treatment on prevention and treatment of COVID-19 with vaccinations, antiviral drugs, and monoclonal antibodies were discussed. The session concluded with a presentation on the perspectives of patient research partners about their experiences with COVID-19.

Clinical Institute

Orthopedics & Sports Medicine

Department

Orthopedics

Department

Rheumatology

Recommended Citation

Mease, Philip; Nash, Peter; Grieb, Suzanne; and Chandran, Vinod, "Impact of COVID-19 on Patients With Psoriasis or Psoriatic Arthritis." (2023). Articles, Abstracts, and Reports. 7787.
https://digitalcommons.providence.org/publications/7787